Literature DB >> 11991834

Interferon-inducible p202 in the susceptibility to systemic lupus.

Divaker Choubey1, Brian L Kotzin.   

Abstract

Systemic lupus erythematosus (SLE) is the prototype systemic autoimmune disease, which has potential to involve multiple organ systems. Studies in human SLE patients and murine models of lupus have indicated that genetic predisposition plays a crucial role in the development of this disease. To identify the genetic basis of human lupus and to understand the molecular mechanisms, mouse models of SLE have been studied. Generation of mice congenic for the Nba2 locus on the C57BL/6 genetic background, coupled with gene expression profiling, recently identified the interferon-activatable Ifi202 gene (encodes the protein p202) as a candidate lupus-susceptibility gene. The protein p202 is a member of the 200-protein family. The family includes structurally and functionally related mouse and human interferon-inducible proteins. The protein p202 (52-kDa) is a relatively well-characterized phosphoprotein in the family with demonstrated ability to control cell-signaling pathways regulating cell proliferation, survival, and differentiation. Here, we review what is known about the gene Ifi202 and the protein it encodes. Moreover, we discuss how an understanding of the role of p202 in cell growth regulation, particularly in cells of the immune system, will help elucidate the molecular mechanisms contributing to the development of lupus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991834     DOI: 10.2741/A921

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  25 in total

Review 1.  Interferons in autoimmune and inflammatory diseases: regulation and roles.

Authors:  Divaker Choubey; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

Review 2.  Interferon-inducible Ifi200-family genes in systemic lupus erythematosus.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Immunol Lett       Date:  2008-07-01       Impact factor: 3.685

3.  Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE.

Authors:  Ravichandran Panchanathan; Xin Duan; Muthuvel Arumugam; Hui Shen; Hongzhu Liu; Divaker Choubey
Journal:  Mol Immunol       Date:  2011-09-23       Impact factor: 4.407

Review 4.  Absent in Melanoma 2 proteins in SLE.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Clin Immunol       Date:  2017-01-03       Impact factor: 3.969

Review 5.  Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins.

Authors:  Sudhakar Veeranki; Divaker Choubey
Journal:  Immunol Lett       Date:  2010-06-26       Impact factor: 3.685

6.  Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus.

Authors:  Ravichandran Panchanathan; Xin Duan; Hui Shen; Vijay A K Rathinam; Loren D Erickson; Katherine A Fitzgerald; Divaker Choubey
Journal:  J Immunol       Date:  2010-11-05       Impact factor: 5.422

Review 7.  DNA-responsive inflammasomes and their regulators in autoimmunity.

Authors:  Divaker Choubey
Journal:  Clin Immunol       Date:  2011-12-29       Impact factor: 3.969

Review 8.  Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.

Authors:  Divaker Choubey
Journal:  Immunol Lett       Date:  2012-07-24       Impact factor: 3.685

Review 9.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

10.  Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene.

Authors:  Lynda Li Song; Larissa Ponomareva; Hui Shen; Xin Duan; Fatouma Alimirah; Divaker Choubey
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.